The function of miR-4651 in HCC development was fully elucidated, and we identified a novel pathway, miR-4651/FOXP4 axis, in HCC development, which could be a clinical therapeutic target for HCC patients. The gene discussed is FOXP4; the disease is hepatocellular carcinoma.